Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 468 results for "cadila healthcare"

NPPA rejects Cadila Healthcare's review plea against price fix...

The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has once again rejected Cadila Healthcare's review application against fixation/revision of ceiling prices of dexamethasone injection 4mg/ml. Earlier, the NPPA vide ... PharmaBiz, 4 days ago

9 images for cadila healthcare, 3 weeks ago, 3 weeks ago
Forbes India, 3 weeks ago
Financial Express, 1 month ago
Business Standard India, 2 weeks ago
NDTV Profit, 1 month ago
NDTV Profit, 1 month ago
NDTV Profit, 1 month ago
Business Standard, 1 month ago
Forbes India

CADILA HEALTHCARE : Bt500 rankings: india's most valuable top-500 companies - cadila healthcare limited

Cadila Healthcare Limited (CHL) has been ranked 77th in the Business Today magazine's Most Valuable Top-500 Companies, based on average market capitalisation for Apr- Sep 2014 . The average market capitalisation of CHL was at Rs22,135 crore ( ...
 4 Traders1 week ago Cadila Healthcare 2QFY2015 performance highlights and results update  Stock Markets Review2 weeks ago For Cadila Healthcare's Pankaj Patel, Patents Are Key to Growth  Forbes India3 weeks ago Cadila Healthcare to hold board meeting  Business Standard1 month ago

Cadila Healthcare Q2 net profit up

(MarketLine via COMTEX News Network) -- Cadila Healthcare Limited, a manufacturer of pharmaceutical ingredients and dosage formulations, has reported that net profit after taxes, minority interest and share of profit of associates for the second ...
 PredictWallStreet1 week ago Pharma Earnings in India Rise, Bank of Baroda Net Falls  Ticker3 weeks ago Cadila Healthcare Q2 net up 52% at Rs 278 crore  The Financial Chronicle3 weeks ago Cadila Healthcare Q2 Net Rises 52%  NDTV Profit3 weeks ago

Hospaccx Healthcare Business Consulting Pvt Ltd

Company Details Managing Director & CEO: Tarun Katiyar Management Team: Hemant Khavle Senior Consultant; PrakartiShrivastava Head West Zone; Snakalp Nagar Head Operations Year of Inception: 2009 Employees Strength: 22 Head Office ...
 EHealth Magazine1 week ago

Type 2 Diabetes - Pipeline Review, H2 2014 - New Study Released

Global Markets Direct's, 'Type 2 Diabetes - Pipeline Review, H2 2014', provides an overview of the Type 2 Diabetes's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete ...
 CEOWorld Magazine2 days ago

Srikakulam plant gets Form 483 for lapses: DRL

Joining the USFDA's list of offenders this year, under warth Dr Reddy's labs has received Form 483 for their Srikakulam Plant, indicating their non-confirmation to the manufacturing standards laid down by the regulatory authority. We have received ...
 Financial Chronicle2 days ago

Supernus files lawsuit against Zydus in US court for infringement of patents covering its antiepileptic drug, Trokendi XR

Supernus Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing products for the treatment of CNS disease, sannounced that it sued generic drug makers Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare ...
 PharmaBiz4 days ago Supernus Pharmaceuticals Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR  BioSpace3 days ago

Supernus sues Zydus for infringement of Trokendi XR patents

US drugmaker Supernus Pharmaceuticals (Nasdaq: SUPN) has sued generic drug makers Zydus Pharmaceuticals (USA) and Indian parent Cadila Healthcare for infringement of three patents covering its antiepileptic drug Trokendi (topiramate) XR. ...
 Pharma Letter3 days ago Supernus Pharmaceuticals Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents  BioSpace4 days ago Supernus Pharmaceuticals : Sues Zydus for Infringement of Trokendi XR(R) Patents  4 Traders6 days ago

Supernus Files Trokendi XR Patent Infringement Lawsuit

Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals ( USA ) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus antiepileptic drug, Trokendi ...
 Yahoo! Finance3 days ago

Net sales of 50 major pharma cos up by 14%, EBDITA by 15.5% in first half of 2014-15

Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...
 PharmaBiz4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less